Much like cardiomyopathy mutations in beta-cardiac myosin which can be gain or loss of function, mutations in MYO3A can alter motor activity in either direction, leading to changes in its ability to control protrusion length and elongation. The gene discussed is MYO3A; the disease is cardiomyopathy.